» Articles » PMID: 21451501

The Role of IL-10 in Immune Regulation During M. Tuberculosis Infection

Overview
Journal Mucosal Immunol
Publisher Elsevier
Date 2011 Apr 1
PMID 21451501
Citations 245
Authors
Affiliations
Soon will be listed here.
Abstract

During gaseous exchange the lungs are exposed to a vast variety of pathogens, allergens, and innocuous particles. A feature of the lung immune response to lung-tropic aerosol-transmitted bacteria such as Mycobacterium tuberculosis (Mtb) is a balanced immune response that serves to restrict pathogen growth while not leading to host-mediated collateral damage of the delicate lung tissues. One immune-limiting mechanism is the inhibitory and anti-inflammatory cytokine interleukin (IL)-10. IL-10 is made by many hematopoietic cells and a major role is to suppress macrophage and dendritic cell (DC) functions, which are required for the capture, control, and initiation of immune responses to pathogens such as Mtb. Here, we review the role of IL-10 on bacterial control during the course of Mtb infection, from early innate to adaptive immune responses. We propose that IL-10 is linked with the ability of Mtb to evade immune responses and mediate long-term infections in the lung.

Citing Articles

Development of Anti-Inflammatory Agents Utilizing DC-SIGN Mediated IL-10 Secretion in Autoimmune and Immune-Mediated Disorders: Bridging Veterinary and Human Health.

Baek H, Yang S, Kim S, Lee Y, Park H, Park M Int J Mol Sci. 2025; 26(5).

PMID: 40076949 PMC: 11901132. DOI: 10.3390/ijms26052329.


Amoxicillin-induced bacterial gut dysbiosis decreases IL-1β and IL-6 expression but exacerbate lung inflammatory response against Mycobacterium bovis-Bacille Calmette-Guérin (BCG).

Miyauchi-Tavares T, Silva E, Dos Santos J, Sousa P, Braga M, Carminatti C PLoS One. 2025; 20(2):e0319382.

PMID: 40009606 PMC: 11864530. DOI: 10.1371/journal.pone.0319382.


Hypercoagulability in Tuberculosis: Pathophysiological Mechanisms, Associated Risks, and Advances in Management-A Narrative Review.

Mitroi D, Balteanu M, Cioboata R, Vlasceanu S, Zlatian O, Catana O J Clin Med. 2025; 14(3).

PMID: 39941433 PMC: 11818899. DOI: 10.3390/jcm14030762.


Biogenic silver nanoparticle as an adjuvant in an S1 subunit recombinant vaccine.

de Freitas S, Neto A, Panagio L, Collares T, Seixas F, Sousa F Braz J Microbiol. 2025; .

PMID: 39878824 DOI: 10.1007/s42770-025-01613-0.


A subunit vaccine Ag85A-LpqH focusing on humoral immunity provides substantial protection against tuberculosis in mice.

Zeng L, Zuo Y, Tang M, Lei C, Li H, Ma X iScience. 2025; 28(1):111568.

PMID: 39868033 PMC: 11760819. DOI: 10.1016/j.isci.2024.111568.